Aurobindo Pharma Limited
NSE: AUROPHARMA | Information Technology
Market Fundamentals
Stock Intelligence & News
Aurobindo Pharma Limited
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 22, 2026, titled "Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company". |SUBJECT: Press Release
Read Full Analysis →Aurobindo Pharma Limited
Aurobindo Pharma Limited has informed that the necessary approval from US Federal Trade Commission (FTC) for the acquisition of the Lannett business has been obtained today. |SUBJECT: General Updates
Read Full Analysis →Aurobindo Pharma Shares Rise After US Regulatory Nod For Lannett Purchase
Aurobindo Pharma Shares Rise After FTC Approval Of Lannett Acquisition Expanding US Manufacturing Capacity.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Aurobindo Pharma Clears Major US Regulatory Hurdle In $250 Million Lannett Deal
The Hyderabad-based drugmaker had agreed to acquire Lannett in July 2025 for $250 million as part of its strategy to strengthen its presence in the US generics market.
Read Full Analysis →Get instant alerts when AUROPHARMA breaks news
Join investors who track Aurobindo Pharma Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for AUROPHARMA?
AUROPHARMA is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Aurobindo Pharma Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding AUROPHARMA to your custom watchlist.